{"id":50492,"date":"2022-11-04T11:02:23","date_gmt":"2022-11-04T10:02:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/"},"modified":"2022-11-04T11:02:23","modified_gmt":"2022-11-04T10:02:23","slug":"global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/","title":{"rendered":"Global Bronchodilators Market Report to 2027 &#8211; Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5656500\/bronchodilators-market-global-industry-trends?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=6jsvdx&amp;utm_campaign=1771441+-+Global+Bronchodilators+Market+Report+to+2027+-+Featuring+GlaxoSmithKline%2C+Novartis%2C+Pfizer+and+Sanofi+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Bronchodilators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global bronchodilators market size reached US$ 33.8 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 45.9 Billion by 2027, exhibiting a CAGR of 5.23% during 2021-2027.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nAstraZeneca plc\n<\/li>\n<li>\nBoehringer Ingelheim International GmbH\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd\n<\/li>\n<li>\nGlaxoSmithKline plc\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTeva Pharmaceutical Industries Ltd.\n<\/li>\n<li>\nVectura Group plc.\n<\/li>\n<\/ul>\n<p>\nKeeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.\n<\/p>\n<p>\nBronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD). They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier.\n<\/p>\n<p>\nThey are available in the form of tablets, liquid, nebulizer solutions, and metered-dose and dry powder inhalers. Nowadays, bronchodilators are also utilized to enhance the effect of inhaled corticosteroids, which act as a primary treatment to reduce inflammation and prevent flare-ups in asthma.\n<\/p>\n<p>\nA significantly rising number of patients with acute respiratory infections due to coronavirus disease (COVID-19) represents one of the key factors influencing the need for bronchodilators across the globe. Apart from this, increasing levels of air pollution, the rising number of smokers, and the growing prevalence of infectious diseases around the world are contributing to the risk of developing lung conditions.\n<\/p>\n<p>\nThis is acting as another growth-inducing factor of the market. In addition, lung function declines gradually with age, which can make breathing slightly difficult. This, along with the increasing geriatric population and a considerable rise in consumer spending capacities, is driving the market.\n<\/p>\n<p>\nOther factors, such as improving healthcare infrastructure and diagnostic modalities and rising shift towards non-invasive procedures, are also propelling the market growth. Furthermore, several new classes of bronchodilators that can help overcome the limitations of existing products are in the preclinical phase stage. In confluence with this, health agencies of numerous countries are supporting research and development (R&amp;D) activities for bronchodilators, which is anticipated to create a positive outlook for the market.\n<\/p>\n<p>\n<strong>Key Market Segmentation:<\/strong>\n<\/p>\n<p>\nThe publisher provides an analysis of the key trends in each sub-segment of the global bronchodilators market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on indication, drug type and route of administration.\n<\/p>\n<p>\n<strong>Breakup by Indication:<\/strong>\n<\/p>\n<ul>\n<li>\nAsthma\n<\/li>\n<li>\nChronic Obstructive Pulmonary Disease (COPD)\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Drug Type:<\/strong>\n<\/p>\n<ul>\n<li>\nSympathomimetics\n<\/li>\n<li>\nAnticholinergics\n<\/li>\n<li>\nPhosphodiesterase Inhibitor\n<\/li>\n<li>\nCombination Drugs\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Route of Administration:<\/strong>\n<\/p>\n<ul>\n<li>\nOral\n<\/li>\n<li>\nInjection\n<\/li>\n<li>\nInhaler\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Region:<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nUnited States\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nIndonesia\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nUnited Kingdom\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRussia\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nMiddle East and Africa\n<\/li>\n<\/ul>\n<p>\n<strong>Key Questions Answered in This Report:<\/strong>\n<\/p>\n<ul>\n<li>\nHow has the global bronchodilators market performed so far and how will it perform in the coming years?\n<\/li>\n<li>\nWhat has been the impact of COVID-19 on the global bronchodilators market?\n<\/li>\n<li>\nWhat are the key regional markets?\n<\/li>\n<li>\nWhat is the breakup of the market based on the indication?\n<\/li>\n<li>\nWhat is the breakup of the market based on the drug type?\n<\/li>\n<li>\nWhat is the breakup of the market based on the route of administration?\n<\/li>\n<li>\nWhat are the various stages in the value chain of the industry?\n<\/li>\n<li>\nWhat are the key driving factors and challenges in the industry?\n<\/li>\n<li>\nWhat is the structure of the global bronchodilators market and who are the key players?\n<\/li>\n<li>\nWhat is the degree of competition in the industry?\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5656500\/bronchodilators-market-global-industry-trends?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=6jsvdx&amp;utm_campaign=1771441+-+Global+Bronchodilators+Market+Report+to+2027+-+Featuring+GlaxoSmithKline%2C+Novartis%2C+Pfizer+and+Sanofi+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/tip8nd<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;o:&#x70;&#x72;&#x65;&#x73;&#115;&#64;re&#x73;&#x65;&#x61;&#114;&#99;&#104;an&#x64;&#x6d;&#x61;&#114;&#107;et&#x73;&#x2e;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">press&#64;re&#115;&#101;&#97;&#114;&#99;&#104;&#97;&#110;&#100;&#109;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Bronchodilators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global bronchodilators market size reached US$ 33.8 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 45.9 Billion by 2027, exhibiting a CAGR of 5.23% during 2021-2027. Companies Mentioned &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50492","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Bronchodilators Market Report to 2027 - Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Bronchodilators Market Report to 2027 - Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Bronchodilators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global bronchodilators market size reached US$ 33.8 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 45.9 Billion by 2027, exhibiting a CAGR of 5.23% during 2021-2027. Companies Mentioned ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-04T10:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Bronchodilators Market Report to 2027 &#8211; Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-04T10:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/\"},\"wordCount\":692,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005287\\\/en\\\/1625908\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Bronchodilators Market Report to 2027 - Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005287\\\/en\\\/1625908\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-04T10:02:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005287\\\/en\\\/1625908\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221104005287\\\/en\\\/1625908\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Bronchodilators Market Report to 2027 &#8211; Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Bronchodilators Market Report to 2027 - Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Bronchodilators Market Report to 2027 - Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Bronchodilators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global bronchodilators market size reached US$ 33.8 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 45.9 Billion by 2027, exhibiting a CAGR of 5.23% during 2021-2027. Companies Mentioned ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-04T10:02:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Bronchodilators Market Report to 2027 &#8211; Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-11-04T10:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/"},"wordCount":692,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/","name":"Global Bronchodilators Market Report to 2027 - Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/21\/logo.jpg","datePublished":"2022-11-04T10:02:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221104005287\/en\/1625908\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-bronchodilators-market-report-to-2027-featuring-glaxosmithkline-novartis-pfizer-and-sanofi-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Bronchodilators Market Report to 2027 &#8211; Featuring GlaxoSmithKline, Novartis, Pfizer and Sanofi Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50492"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50492\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}